Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chicken embryos were inoculated with chicken embryos mixed with chicken newcastle virus ii strains and chicken pox virus weak strains, chicken infectious bronchitis virus H120 strains were inoculated with chicken embryos alone, chicken embryo solution and villurionic allantouria membrane were harvested, homogenized in a certain proportion, stabilizer was added, and dried by freezing vacuum.
Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Veterinary Drug and Scientific Research are the major drivers for the industry.
Global demand for poultry products such as chicken and eggs continues to grow owing to factors such as population growth, increasing disposable income, and changing dietary preferences. This increased demand requires healthier and more efficient poultry farming methods, including vaccinations to prevent disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Pulike
Luoyang Huizhong Biotechnology Co., Ltd.
Segment by Type
Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
Segment by Application
Veterinary Drug
Scientific Research
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine introduction, etc. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Table of Content
1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Overview
1.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Overview
1.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Segment by Type
1.2.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
1.2.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
1.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Type
1.3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Type (2018-2024)
2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Competition by Company
2.1 Global Top Players by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (2018-2024)
2.2 Global Top Players by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (2018-2024)
2.3 Global Top Players by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
2.5.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market
2.8 Key Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Status and Outlook by Region
3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Region
3.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Region
3.3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Application
4.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Segment by Application
4.1.1 Veterinary Drug
4.1.2 Scientific Research
4.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Application
4.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Breakdown by Application (2018-2024)
5 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Country
5.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Country
5.1.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2018-2024)
5.2 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Country
5.2.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2029)
6 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Country
6.1 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Country
6.1.1 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Region
7.1 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2029)
8 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Country
8.1 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Country
8.1.1 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Country
9.1 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 Pulike
10.2.1 Pulike Company Information
10.2.2 Pulike Introduction and Business Overview
10.2.3 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Products Offered
10.2.5 Pulike Recent Development
10.3 Luoyang Huizhong Biotechnology Co., Ltd.
10.3.1 Luoyang Huizhong Biotechnology Co., Ltd. Company Information
10.3.2 Luoyang Huizhong Biotechnology Co., Ltd. Introduction and Business Overview
10.3.3 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Products Offered
10.3.5 Luoyang Huizhong Biotechnology Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industrial Chain Analysis
11.4 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Dynamics
11.4.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Trends
11.4.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
11.4.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Challenges
11.4.4 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Distributors
12.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figure
List of Tables
Table 1. Major Company of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
Table 2. Major Company of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
Table 3. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (Box)
Table 5. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Type (2018-2024) & (US$/Box)
Table 9. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2024-2029) & (Box)
Table 10. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Type (2024-2029) & (US$/Box)
Table 14. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (Box)
Table 15. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2018-2024)
Table 17. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2018-2024)
Table 19. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2018-2024)
Table 21. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2018-2024)
Table 23. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Company (2018-2024) & (Box)
Table 25. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Share by Company (2018-2024)
Table 26. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Company (2018-2024) & (US$/Box)
Table 29. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market
Table 33. Key Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2018-2024) & (Box)
Table 37. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 41. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2024-2029) & (Box)
Table 42. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2024-2029)
Table 46. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (Box)
Table 48. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Application (2018-2024) & (US$/Box)
Table 52. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2024-2029) & (Box)
Table 53. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Application (2024-2029) & (US$/Box)
Table 57. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) (Box)
Table 58. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) (Box)
Table 60. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) (Box)
Table 62. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) (Box)
Table 64. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) (Box)
Table 66. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (Box)
Table 68. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (Box)
Table 72. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (Box)
Table 76. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (Box)
Table 80. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2018-2024) & (Box)
Table 84. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2024-2029) & (Box)
Table 88. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (Box)
Table 92. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (Box)
Table 96. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (Box)
Table 100. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (Box)
Table 104. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Boehringer Ingelheim Company Information
Table 108. Boehringer Ingelheim Introduction and Business Overview
Table 109. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 110. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
Table 111. Boehringer Ingelheim Recent Development
Table 112. Pulike Company Information
Table 113. Pulike Introduction and Business Overview
Table 114. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 115. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
Table 116. Pulike Recent Development
Table 117. Luoyang Huizhong Biotechnology Co., Ltd. Company Information
Table 118. Luoyang Huizhong Biotechnology Co., Ltd. Introduction and Business Overview
Table 119. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 120. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
Table 121. Luoyang Huizhong Biotechnology Co., Ltd. Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Trends
Table 125. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
Table 126. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Challenges
Table 127. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Restraints
Table 128. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Distributors List
Table 129. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Downstream Customers
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Status and Outlook (2018-2029) & (Box)
Figure 5. Product Picture of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
Figure 6. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live Sales YoY Growth (2018-2029) & (Box)
Figure 7. Product Picture of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
Figure 8. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated Sales YoY Growth (2018-2029) & (Box)
Figure 9. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue in 2022
Figure 23. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Veterinary Drug
Figure 25. Global Veterinary Drug Sales YoY Growth (2018-2029) & (Box)
Figure 26. Product Picture of Scientific Research
Figure 27. Global Scientific Research Sales YoY Growth (2018-2029) & (Box)
Figure 28. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturing Cost Structure
Figure 41. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices